IBA Q1 revenues fall 14 percent as fails to covert orders
BRUSSELS May 8 (Reuters) - Belgian cancer treatment company Ion Beam Applications said on Wednesday its first-quarter sales fell 13.9 percent as it signed fewer deals for its radiation therapy devices.
The firm said that it has seen a low conversion rate for its existing backlog in the quarter, but added that this was not unusual and it expects to make sales in the second half of the year.
The company, which specialises in proton therapy, a highly targeted radiation treatment used for tumours in the face and neck, reiterated it expects to sign deals for eight to 12 proton therapy rooms in 2013. (Reporting By Ben Deighton)
- Exclusive: Secret contract tied NSA and security industry pioneer |
- Housing, jobs data weaken, but overall economic picture still upbeat
- Putin critic Khodorkovsky in Germany after pardon |
- Target probe looks overseas, stolen cards offered online
- Pizza outlet attacked as India, U.S. fail to cool diplomat row |